Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program.

[1]  S. Erickson,et al.  Self-Reported Adherence in Patients with Asthma , 2006, The Annals of pharmacotherapy.

[2]  H. Aizawa,et al.  Characterisation of patients with frequent exacerbation of asthma. , 2006, Respiratory medicine.

[3]  S. Wenzel,et al.  Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma. , 2005, The Journal of allergy and clinical immunology.

[4]  Charles A. Johnson,et al.  Severity assessment in asthma: An evolving concept. , 2005, The Journal of allergy and clinical immunology.

[5]  A. Zwinderman,et al.  Risk factors of frequent exacerbations in difficult-to-treat asthma , 2005, European Respiratory Journal.

[6]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[7]  W. Busse,et al.  Correlation of systemic superoxide dismutase deficiency to airflow obstruction in asthma. , 2005, American journal of respiratory and critical care medicine.

[8]  S. Wenzel,et al.  Severe asthma in adults. , 2005, American journal of respiratory and critical care medicine.

[9]  W. Schaffner,et al.  Asthma as a risk factor for invasive pneumococcal disease. , 2005, The New England journal of medicine.

[10]  Carlos A Camargo,et al.  Asthma exacerbations in North American adults: who are the "frequent fliers" in the emergency department? , 2005, Chest.

[11]  C. Iribarren,et al.  Intensive Care Unit Admission for Asthma: A Marker for Severe Disease , 2005, The Journal of asthma : official journal of the Association for the Care of Asthma.

[12]  A. Wu,et al.  Relationship of physician estimate of underlying asthma severity to asthma outcomes. , 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[13]  G. Colice.  Categorizing asthma severity: an overview of national guidelines. , 2004, Clinical medicine & research.

[14]  P. Barnes,et al.  Parameters associated with persistent airflow obstruction in chronic severe asthma , 2004, European Respiratory Journal.

[15]  Gert Folkerts,et al.  Nitric Oxide in Health and Disease of the Respiratory System , 2022 .

[16]  C. Bucca,et al.  Asthma severity and medical resource utilisation , 2004, European Respiratory Journal.

[17]  J. C. Carranza Rosenzweig,et al.  Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies. , 2004, The Journal of allergy and clinical immunology.

[18]  E. Jacobs,et al.  Agreement of Self-Reported Medical History: Comparison of an In-Person Interview with a Self-Administered Questionnaire , 2003, European Journal of Epidemiology.

[19]  Charles A. Johnson,et al.  Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. , 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[20]  S. Wenzel,et al.  Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. , 2004, The Journal of allergy and clinical immunology.

[21]  K. Schechtman,et al.  Causative and contributive factors to asthma severity and patterns of medication use in patients seeking specialized asthma care. , 2003, Chest.

[22]  E. Gelfand,et al.  A comparison of the clinical characteristics of children and adults with severe asthma. , 2003, Chest.

[23]  D. Postma,et al.  The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma , 2003, European Respiratory Journal.

[24]  P. Silkoff,et al.  Exhaled nitric oxide in asthma: from bench to bedside. , 2003, The Journal of allergy and clinical immunology.

[25]  Brigit VanGraafeiland,et al.  National Asthma Education and Prevention Program. , 2002, The Nurse practitioner.

[26]  L. Semple,et al.  Near-fatal asthma: a population-based study of risk factors. , 2002, Chest.

[27]  P Godard,et al.  Costs of asthma are correlated with severity: a 1-yr prospective study , 2002, European Respiratory Journal.

[28]  R. Dweik,et al.  NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Bousquet,et al.  Rhinosinusitis in severe asthma. , 2001, The Journal of allergy and clinical immunology.

[30]  W. Busse,et al.  Pathophysiology of severe asthma. , 2000, The Journal of allergy and clinical immunology.

[31]  D Curran-Everett,et al.  Multiple comparisons: philosophies and illustrations. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[32]  K. Chung,et al.  Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in mild to moderately severe asthma , 2000, Thorax.

[33]  M. Bala,et al.  Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique. , 2000, Chest.

[34]  S. Spector,et al.  Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. , 2000, American journal of respiratory and critical care medicine.

[35]  A. Wu,et al.  Treatment patterns among adult patients with asthma: factors associated with overuse of inhaled beta-agonists and underuse of inhaled corticosteroids. , 1999, Archives of internal medicine.

[36]  S. Yancey,et al.  Efficacy of salmeterol xinafoate in the treatment of COPD. , 1999, Chest.

[37]  V. Plaza,et al.  Costs of asthma according to the degree of severity. , 1998, The European respiratory journal.

[38]  S. Durham,et al.  Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids , 1998, Thorax.

[39]  S. Vedal,et al.  Risk factors for near-fatal asthma. A case-control study in hospitalized patients with asthma. , 1998, American journal of respiratory and critical care medicine.

[40]  Third Expert Panel on theDiagnosis,et al.  Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma , 1997 .

[41]  J. Bousquet,et al.  Long-term oral corticosteroid therapy does not alter the results of immediate-type allergy skin prick tests. , 1996, The Journal of allergy and clinical immunology.